Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer
Open Access
- 19 November 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 9, 1266
Abstract
With recent advancements in a non-invasive approach to cancer diagnosis and surveillance, the term “liquid biopsy” has gained traction but is currently limited by technological challenges in identifying and isolating circulating tumor cells (CTCs), proteins, cell-free DNA (cfDNA), or other nucleic acids. Tumor tissue biopsy, especially in genitourinary (GU) system is sometimes inadequate and requires invasive surgical options, especially for upper tract urothelial cancer. Urine can prove to be “liquid gold” since it may be a more abundant source of tumor-derived material without the background noise; however, urine DNA (uDNA) may be associated with low mutant allele fraction (MAF). Molecular detection of mutations in uDNA requires a sensitive and accurate method of analysis that allows a high depth of sequencing while minimizing artifacts. Several sequencing approaches to address this hurdle using enhanced library preparation techniques such as Tagged amplicon deep sequencing (TAm-Seq), Safe-SeqS, FAST-SeqS, and CAPP-Seq approaches have been developed. Urine biopsy utilizing next-generation sequencing (NGS) can prove useful at all stages of urologic malignancy care, where urine can be collected to aid in clinical decision making through the identification of commonly known mutations, and potentially reduce or avoid all forms of invasive procedures.Keywords
This publication has 77 references indexed in Scilit:
- Highly Recurrent TERT Promoter Mutations in Human MelanomaScience, 2013
- Detection of ultra-rare mutations by next-generation sequencingProceedings of the National Academy of Sciences, 2012
- FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel SequencingPLOS ONE, 2012
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy NumberAnalytical Chemistry, 2011
- Field guide to next‐generation DNA sequencersMolecular Ecology Resources, 2011
- Detection and quantification of rare mutations with massively parallel sequencingProceedings of the National Academy of Sciences, 2011
- Small Endoscopic Biopsies of the Ureter and Renal PelvisAmerican Journal of Surgical Pathology, 2009
- Aneuploidy in bladder cancers: the utility of fluorescent in situ hybridization in clinical practiceBJU International, 2006
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003
- Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) TumorsThe American Journal of Pathology, 2001